Interactive Exergaming with Otago Exercise Program: Participants will receive a 12-week structured program combining interactive exergaming and Otago Exercise Program. Sessions include balance training, strength exercises, and functional mobility activities delivered through interactive gaming platforms, supervised by trained instructors.
Control Group with Usual Care: Participants will maintain their regular activities at community centers or facilities, including cognitive therapy, oral exercises, and upper limb training programs, during the 12-week study period
This clinical trial aims to evaluate the effectiveness of interactive exergaming combined with Otago Exercise Program on mobility among community-dwelling older adults aged 65 and above. The main research questions are:
Does this combined exercise intervention improve elderly mobility? Does this program enhance muscle strength and psychological well-being?
Researchers will compare two groups: one group will do the combined exercise program for 12 weeks, while the other group will continue their usual activities.
Participants will:
* Have their health checked three times: at the start, after 12 weeks, and 3 months later
* If in the exercise group, attend exercise sessions twice a week for 12 weeks
* Complete tests about their physical abilities and how they feel emotionally
Who can take part:
* Adults age 65 or older
* People who need more than 12 seconds to stand up and sit down 5 times
* People who can stand for at least 30 seconds with support
People cannot take part if they have serious vision problems, recent leg injuries, major illnesses, significant memory problems, or mental health conditions.
| Facility | City | Region | Status |
|---|---|---|---|
| No. 105, Yusheng Street, Shilin District, Taipei City 111, Taiwan | Taipei | Taipei |
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06814678 on ClinicalTrials.gov ↗ ← All trials in Taiwan